KOL Mapping for Established Leaders

📄 MODULE 1 OF 6  |  Slug: /kol-mapping-established-leaders/

KOL Mapping for Established Leaders: Evidence-Based Authority Mapping for Pharma

Established KOLsAuthority MappingPharma & Biotech

Every pharma and biotech programme needs a rigorous, evidence-based picture of who holds recognised authority in its therapy area — not a publication-weighted ranked list, but a genuinely multidimensional view of who the experts are, what they stand for, where they sit in the network, and why they matter to your specific strategic objectives.

KOL Mapping by VML’s Established Leader module is the foundation of expert ecosystem intelligence — the starting point for most KOL mapping programmes and the module that sets the analytical standard all other insights are built on.

What This Module Delivers

  • A tiered expert shortlist covering global, regional, and local KOLs in your therapy area and geographies
  • Individual expert profiles with evidence summary, scientific positions, engagement history, and strategic fit assessment
  • Multidimensional authority scoring based on publications, trials, congress roles, guidelines, and peer network position
  • Clear identification of which experts matter most for your specific objectives — not just who publishes most
  • Full methodology documentation for compliance and internal review

The Problem with Standard KOL Lists

Most organisations approach established KOL identification with a publication database search, a congress attendee list, and their team’s accumulated memory. The result is a list that over-represents familiar names, reflects recent engagement history more than genuine authority, and systematically misses experts whose influence operates through channels — guideline committees, peer consultation networks, hospital leadership — that standard searches do not capture.

A publication-weighted ranking answers one question: “Who has published the most?” KOL Mapping by VML’s established leader mapping answers a more strategically useful question: “Who actually holds authority in this therapy area — and why?”


How the Established Leader Module Works

  1. Scope definition — therapy area, indication, geographies, and strategic objective agreed with the client team
  2. Multi-source data gathering — publications, clinical trials, congress proceedings, guideline documents, and field intelligence gathered simultaneously across all specified geographies
  3. Expert identification — systematic identification of established experts across all evidence dimensions, not limited to easily searchable databases
  4. Multidimensional profiling — each identified expert profiled across publication authority, trial leadership, congress prominence, guideline contribution, and peer network position
  5. Tiering and prioritisation — experts tiered by geographic scope of influence (global/regional/local) and prioritised by alignment to the programme’s specific objectives
  6. Validation — outputs reviewed and, where the KOL Validation module is included, additionally verified through desk research and direct checks
  7. Deliverable production — tiered shortlists, expert profiles, and methodology documentation structured for the client’s specific team needs

What Makes This Module Different

The established leader module at KOL Mapping by VML draws on 15+ years of specialist experience mapping expert authority across therapy areas, geographies, and product lifecycle stages. The methodological rigour — multi-source triangulation, systematic geography coverage, transparent scoring — produces outputs that are both more complete and more defensible than those produced by generic database platforms or in-house approaches.

Built on the foundations of System Analytic — one of pharma’s original specialist KOL mapping companies, now part of VML, a WPP company. The methodology has been refined across 15+ years of delivery across multiple therapy areas and geographies.

Frequently Asked Questions

How does KOL Mapping by VML identify established KOLs beyond publication databases?

By triangulating six independent data source categories: publications (including citation networks and co-authorship patterns), clinical trial investigator roles, congress activity (speaker, chair, abstract), guideline and policy committee memberships, digital presence, and — where available — MSL and field team interaction intelligence. Each source reveals a different dimension of authority; together they produce a far more complete picture than publication data alone.

Can established leader mapping cover multiple geographies in a single programme?

Yes. Multi-geography coverage is a standard feature of KOL Mapping by VML programmes. Each geography is covered using geography-specific data sources — national trial registries, local congress proceedings, regional guideline documents — ensuring that global, regional, and local KOLs are identified in each specified market, not just the markets where your field team is most active.

Build a Rigorous Foundation for Your Expert Engagement Programme

→ Talk to KOL Mapping by VML about your therapy areas and geographies